# REZLIDHIA

NDC: 71332-005
Generic name: olutasidenib
Labeler / Manufacturer: Rigel Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20221201

FDA application: NDA215814

## Active ingredients

- OLUTASIDENIB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71332-005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71332-005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a0c7c8b-b95f-455d-9600-b7351e4397fe